Related Experiment Video
Updated: Jul 11, 2026
13:10
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
RNA interference as a gene-specific approach for molecular medicine
1Institute for Pharmaceutical Chemistry, Philipps-Universität Marburg, Germany. gruenwel@staff.uni-marburg.de
Current Medicinal Chemistry
|December 27, 2005
Summary
RNA interference (RNAi) is a powerful gene silencing tool revolutionizing genetics and disease treatment. Small interfering RNAs (siRNAs) show promise for treating genetic diseases, with ongoing clinical trials for conditions like macular degeneration.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- RNA interference (RNAi) is a significant breakthrough in eukaryotic cells.
- RNAi pathways regulate gene expression, defend the genome, and influence chromatin structure.
- The ability of RNAi to specifically silence genes using double-stranded RNA (dsRNA) has transformed modern genetics.
Purpose of the Study:
- To highlight the revolutionary impact of RNAi in functional genomics and disease modeling.
- To discuss the therapeutic potential of small interfering RNAs (siRNAs) for genetic diseases.
- To outline advancements and future directions in RNAi technology for therapeutic applications.
Main Methods:
- RNAi-based functional genomics enables genome-wide assessment of gene function in mammals.
- Development of novel animal disease models utilizing RNAi technology.
- Clinical trials investigating siRNA therapies for conditions such as age-related macular degeneration.
Main Results:
- RNAi provides an alternative to traditional knockout methods, overcoming issues with lethal phenotypes.
- Early clinical trials show promise for siRNA-based treatments targeting specific factors like VEGF.
- Ongoing research focuses on improving siRNA design and chemical modifications for enhanced in vivo performance.
Conclusions:
- RNAi has revolutionized genetic research and offers significant therapeutic potential for various diseases.
- Further development in siRNA design, chemical modifications, and delivery strategies is crucial for successful clinical translation.
- Optimized siRNA delivery systems are essential for achieving high specificity, efficiency, and safety in therapeutic applications.
Related Concept Videos
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:31Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...